Invasive Breast Cancer

specific

A carcinoma that infiltrates the breast parenchyma. The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU). Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ. It is the most common carcinoma affecting women.

41

Centers

29

Active Trials

$64M

Cancer Funding

Top Centers for Invasive Breast Cancer(41)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
75.1
2
NCI Comprehensive
High-Volume Research Center
74.1
3
High-Volume Research Center
71.0
4
NCI Comprehensive
Active Research Program
66.5
5
NCI Comprehensive
Active Research Program
63.0
6
NCI Comprehensive
Active Research Program
62.1
7
NCI Comprehensive
Active Research Program
61.3
8
NCI Comprehensive
Active Research Program
60.1
9
NCI Comprehensive
Active Research Program
59.9
10
Active Research Program
59.9
11
NCI Comprehensive
Active Research Program
59.6
12
NCI Comprehensive
Active Research Program
59.2
13
NCI Comprehensive
Active Research Program
58.4
14
NCI Comprehensive
Active Research Program
57.9
15
NCI Comprehensive
Active Research Program
57.5
16
NCI Comprehensive
Active Research Program
57.1
17
NCI Comprehensive
Active Research Program
56.6
18
NCI Comprehensive
Active Research Program
55.8
19
NCI Comprehensive
Active Research Program
54.1
2053.2
21
NCI Comprehensive
Active Research Program
52.4
22
NCI Comprehensive
Active Research Program
51.5
23
NCI Comprehensive
Active Research Program
51.1
24
NCI Comprehensive
Active Research Program
51.1
25
Active Research Program
51.1
26
NCI Comprehensive
Active Research Program
50.7
27
NCI Comprehensive
Active Research Program
49.0
28
NCI Comprehensive
Active Research Program
48.1
29
NCI Comprehensive
Active Research Program
46.4
30
NCI Comprehensive
Active Research Program
45.5
31
NCI Comprehensive
Active Research Program
44.7
32
NCI Comprehensive
Active Research Program
41.3
33
NCI Clinical
Active Research Program
39.6
34
NCI Comprehensive
31.9
3531.9
3631.9
3731.9
3831.9
3931.9
40
BC CancerVancouver, BC
31.9
4131.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →